Review
Copyright ©The Author(s) 2021.
World J Gastroenterol. Aug 28, 2021; 27(32): 5306-5321
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5306
Table 1 Overview of the most widely adopted machine learning algorithms in rectal cancer imaging
Algorithm name
Description
Random forestAn ensemble method that combines multiple decision trees (a class of predictive learning models used in supervised ML) to obtain more accurate results for classification and regression tasks
Support vector machineA linear approach used mainly for classification problems with the aim to find the best hyper plane which most accurately separate input data into two classes
Logistic regressionA classifier used to obtain the best fitting model for the relationship between multiple predictor variables and a dichotomous outcome
LASSOA regularized regression method that performs both variable selection and regularization in order to optimally fit the resulting generalized statistical model
Naive BayesA classifier relying on the Bayes Theorem to model the probability of an outcome based on the strong (naive) independence assumptions between the features data
Quadratic discriminant analysisA subtype of Dimensionality Reduction Algorithms that turn high-dimensional data into to low-dimensional data retaining the most significant features of original data for the prediction of the class label
ANNA subgroup of ML composed of neuronal-like multi-layered networks allowing to automatically extract features without prior labelling and perform complex operations
CNNAs subset of ANN containing multiple computational hidden layers that filter and compute high-dimensional data to enhance the learning of high-level tasks (deep learning)
Table 2 Key characteristics of the main studies using radiomics and machine learning algorithms on magnetic resonance images to predict pathologic complete response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
Ref.
Study design (n of sites)
Number of patients
Definition of pCR
MRI field strength (n of scanners)
MRI timing
MRI sequence
ML algorithm
Data powering algorithm
Validation
Performance (AUC)
Antunes et al[59], 2020Retrospective (3)104TRG 0 according to AJCC1.5 and 3 T (> 10)Pre-nCRTT2wRFRadiomics featuresExternal validation0.71
Ferrari et al[106], 2019 Retrospective (1)55TRG 4 according to Dowrak-Rodel3 T (1)Pre-, mid- and post-nCRTT2wRFRadiomics featuresInternal validation (train/test split)0.86
Horvat et al[107], 2018Retrospective (11)114ypT0N01,5 and 3 T (4)Post-nCRTT2wRFRadiomics featuresInternal validation (cross-validation)0.93
Nie et al[108], 2016Retrospective (1)48ypT0N03 T (1)Pre-nCRTT2w, DWI, pre and post-contrast T1wANNRadiomics featuresInternal validation (cross-validation)0.84
Petkovska et al[109], 2020 Retrospective (11)1022ypT0N01,5 and 3 T (4)Pre-nCRTT2wSVMRadiomics and semantic featuresInternal validation (train/test split)0.75
Shaish et al[110], 2020 Retrospective (2)132ypT0N01,5 and 3 T (multiple3)Pre-nCRTT2wLRRadiomics featuresInternal validation (train/test split)0.80
Shi et al[111], 2019 Retrospective (1)51TRG 0 according to Ryan3 T (1)Pre- and mid-Ncrt4T2w, DWI, pre- and post-contrast T1wCNNRadiomics featuresInternal validation (cross-validation)0.83
van Griethuysen et al[60], 2019Retrospective (2)133ypT0/TRG1 according to Mandard1,5 T (3)Pre-nCRTT2w and DWILRRadiomics featuresExternal validation0.77
Yi et al[112], 2019Retrospective (1)134ypT0N01,5 and 3 T (2)Pre-nCRTT2wSVMRadiomics, clinical and semantic featuresInternal validation (train/test split)0.88
Table 3 Key characteristics of the main studies using radiomics and machine learning algorithms on magnetic resonance images to predict outcome other than pathologic complete response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
Ref.
Study design (n of sites)
Number of patients
Prediction task
CT phase (n of CT scanner)
Segmentation method
ML algorithm
Data powering algorithm
Validation
Performance
Bibault et al[85], 2018Retrospective (3)99pCR after nCRTUnenhanced (3)Manual – 3DDNNRadiomics and clinical featuresInternal validation (cross-validation)AUC: 0.72
Hamerla et al[86], 2019Retrospective (1)169pCR after nCRTUnenhanced (1)Manual – 3DRFRadiomics featuresInternal validation (cross-validation)Accuracy: 0.87
Yuan et al[87], 2020Retrospective (1)91pCR after nCRTUnenhanced (1)Manual – 3DRFRadiomics featuresInternal validation (train/validation split)Accuracy: 0.84
Wu et al[90], 2019 Retrospective (1)102MSI statusVenous phase - DECT (2)Manual - 3 2D ROIs for lesionLRRadiomics featuresInternal validation (train/validation /test split)AUC: 0.87
Fan et al[91], 2019Retrospective (1)100MSI statusPortal venous phase (2) Semiautomatic – 3DNBRadiomics featuresInternal validation (cross-validation)AUC: 0.75
Wu et al[92], 2020Retrospective (1)173KRAS mutationPortal venous phase (3)Manual + DL – single 2D ROILRRadiomics featuresInternal validation (train/test split)C-index: 0.83
Wang et al[94], 2019Retrospective (1)411Prediction of survivalUnenhanced (1)Manual – 3D10-F CVRadiomics and clinical featuresInternal validation (cross-validation)C-index: 0.73
Table 4 Key characteristics of the main studies using radiomics and machine learning algorithms on computed tomography for v prediction tasks
Ref.Study design (n of sites)Number of patientsPrediction taskCT phase (n of CT scanner)Segmentation methodML algorithmData powering algorithmValidationPerformance
Bibault et al[85], 2018Retrospective (3)99pCR after nCRTUnenhanced (3)Manual – 3DDNNRadiomics and clinical featuresInternal validation (cross-validation)AUC: 0.72
Hamerla et al[86], 2019Retrospective (1)169pCR after nCRTUnenhanced (1)Manual – 3DRFRadiomics featuresInternal validation (cross-validation)Accuracy: 0.87
Yuan et al[87], 2020Retrospective (1)91pCR after nCRTUnenhanced (1)Manual – 3DRFRadiomics featuresInternal validation (train/validation split)Accuracy: 0.84
Wu et al[90], 2019Retrospective (1)102MSI statusVenous phase - DECT (2)Manual - 3 2D ROIs for lesionLRRadiomics featuresInternal validation (train/validation /test split)AUC: 0.87
Fan et al[91], 2019Retrospective (1)100MSI statusPortal venous phase (2)Semiautomatic – 3DNBRadiomics featuresInternal validation (cross-validation)AUC: 0.75
Wu et al[92], 2020Retrospective (1)173KRAS mutationPortal venous phase (3)Manual + DL – single 2D ROILRRadiomics featuresInternal validation (train/test split)C-index: 0.83
Wang et al[94], 2019Retrospective (1)411Prediction of survivalUnenhanced (1)Manual – 3D10-F CVRadiomics and clinical featuresInternal validation (cross-validation)C-index: 0.73